In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1901 News Items found
MSK thoracic oncologist Kathryn Arbour, MD, seen smiling.
Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations

A heralded drug that experts hope will open a new era in treating pancreatic cancer is also showing early but strong signs it could be effective agains...
An MSK researcher at work in the lab
MSK Research Highlights August 31, 2026

New MSK research identifies a tumor-secreted protein that primes the lungs for metastasis; shows how a new drug combination improves survival in patients with advanced clear cell renal cell carcinoma; and find a three-drug combination works in most patients newly diagnosed with follicular lymphoma.
Dr. Eileen O'Reilly seen smiling in an exam room.
FDA Approves Daraxonrasib for Pancreatic Cancer: What Patients Need To Know

Learn about a new FDA-approved treatment for pancreatic cancer in which MSK experts played a leading role in opening a new world of treatment options.
Family of five posing in the sun behind sign for air strip in Kenya smiling for camera.
Article
How To Lower Ovarian Cancer Risk: Remove the Fallopian Tubes

Learn how a simple surgical procedure can dramatically reduce the risk of developing ovarian cancer.
Gloved hands hold several test tubes of blood with a piece of lab equipment in the background
Liquid Biopsies and Other Blood Tests for Cancer: What You Should Know 

Learn how blood tests called liquid biopsies may be used to find, diagnose, and treat cancer anywhere in the body.
MSK medical oncologist Dr. Michael Morris.
FDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA

Learn more about a new radiopharmaceutical treatment for prostate cancer approved by the FDA for more patients.
MSK patient Anthony Valente and Dr. Alexander Drilon
FDA Approves Zidesamtinib for Lung Cancers With ROS1 Fusions

Zidesamtinib, a new drug that treats non-small cell lung cancer carrying a mutation called a ROS1 fusion, has been approved by the FDA.
MSK patient Joanne Ferrari-Mautino seen outdoors with her son and boyfriend.
How ROS1-Targeted Therapy Is Helping People With Advanced Lung Cancer Live Better, Longer

Learn how MSK is helping people with lung cancer driven by ROS1 fusions, thanks to continual improvements in specific targeted therapies.
Microscope image of cells in a mouse colon
MSK Scientists Find the 'Molecular Switch' That Heals the Gut — And That Colorectal Cancer Hijacks To Spread

MSK researchers identified a protein called ZFP36L2 that acts as a critical "molecular switch" controlling how gut cells repair themselves after injury — a mechanism that colorectal cancer hijacks to spread to other organs. The findings could point toward new treatments that exploit cancer cells' dependence on this protein to stop metastasis or overcome treatment resistance.
Dr. Robin Mendelsohn
Can a Blood Test Detect Colorectal Cancer? Hear From an MSK Expert

MSK experts say blood tests are not the best way to detect colorectal cancer and instead recommend colonoscopy or a stool test for those who can’t have a colonoscopy.